Compare Novavax Inc (NVAX) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Remitly Global Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Remitly Global Inc trades at $23.93 (market cap $5.02B). The key difference: Remitly Global Inc is far larger — about 3.9× Novavax Inc's market cap, and Remitly Global Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | RELY | |
|---|---|---|
Market Cap | $1.30B | $5.02B |
Sector | Health | Technology |
52-Week High | $11.19 | $25.23 |
52-Week Low | $6.22 | $12.20 |
Enterprise Value | $800.50M | $4.41B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
